Benzodiazepine Market to Expand with Significant CAGR of 2.3% by 2022

Market Research Future adds new report of “Benzodiazepine Market Research Report - Forecast to 2022” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players of this market are

• AstraZeneca plc.
• Eli Lilly and Company
• Forest Laboratories Inc.
• GlaxoSmithKline plc.
• H. Lundbeck A/S
• Johnson & Johnson
• Merck & Co. Inc.
• Pfizer Inc.
• Sanofi S.A.

Intended Audience

• Benzodiazepine manufacturers
• Benzodiazepine suppliers
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Government Research Laboratories

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2281

Market Highlight:

Benzodiazepines (BZD) are a class of psychoactive drugs with sedative, hypnotic (sleep-inducing), anti-anxiety, anticonvulsant, and muscle relaxant properties. Benzodiazepines (BZD) are useful in treating anxiety, insomnia, agitation, seizures, muscle spasms and alcohol withdrawal symptoms.

The prescribing of BZD’s as a whole had diminished greatly since their heyday of the 1970s. After the late 1980s, the initial decline of BZD’s was further hastened by the rise of the Selective Serotonin Reuptake Inhibitors (SSRIs) and the shift of psychiatry from anxiety to depression. However the tide turned in favor of BZD’s by the year 2000.

Between 2005 and 2008, 11% of all Americans over the age of 12 took an anti-anxiety medication. This along with the development of Xanax and the inclusion of anti-anxiety medication in health care programs in the U.S. has led to revival of benzodiazepines. Other factor in favor of BZD’s is the weak pipeline of novel anti-anxiety drugs and sluggish growth of 2.5 % CAGR in general anxiety disorder market.

The BZD are proving themselves as a middle ground as compared to other drugs, which has placed them in favorable positions once again, albeit in a declining market. Unless there is discovery of newer safer alternative drugs the BZD’s are here to stay as they have lesser side effects as compared to barbiturates and the lack of efficacy and late onset of action of Selective Serotonin Reuptake Inhibitor (SSRI’s).

Thus taking all these factors together, we expect the Benzodiazepine market to grow at a CAGR of 1.5% to 2.3% by 2022. The International Narcotics Control Board (INCB) reported that Italy (32 %), India (19 %), China (11 %) and Germany (10 %) were the leading manufacturers between 1997 and 2006.

Browse Report Details @ https://www.marketresearchfuture.com/reports/benzodiazepine-market

Market Segments:

Global Benzodiazepine market has been segmented;

• On the basis of Applications; anxiety, insomnia, agitation, seizures, muscle spasms and alcohol withdrawal symptoms and as anesthesia supplements

• On the basis of Time of Action; the market is segmented into long acting and short acting Benzodiazepines

Table of Content

1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Benzodiazepine Market, by Application
6 Global Benzodiazepine Market, by Time of Action
7 Global Benzodiazepine Market, by Regions
8 Company Landscape
9 Company Profile
10 Appendix

List Of Tables

Table 1 Global Benzodiazepine Market, 2013-2022 (Usd Million)
Table 2 Global Benzodiazepine Market, By Application, 2013-2022 (Usd Million)
Table 3 Global Benzodiazepine Market, By Time Of Action, 2013-2022 (Usd Million)
Table 4 Global Benzodiazepine Market, By Region, 2013-2022 (Usd Million)

List of Figures

Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Global Benzodiazepine Market, By Application
Figure 4 Global Benzodiazepine Market, By Time Of Action
Figure 5 Global Benzodiazepine Market, By Region
Figure 6 Global Benzodiazepine Market: Company Share Analysis, 2015 (%)

Enquire about this Report @ https://www.marketresearchfuture.com/enquiry/2281

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.